
KPV Oral 100 × 500mcg Immunology
Tablet formatKPV in tablets. A rare format.
The alpha-MSH tripeptide goes oral. Its small size gives it an oral bioavailability most peptides will never reach: gut, skin and joint inflammatory models, with no injection. 100 pre-dosed 500mcg tablets, HPLC ≥ 98%. EU stock.
Research Use Only (RUO) · Prohibited for human or veterinary use.
Key facts
Protocol and preparation
Asepsis
Disinfect surfaces and stoppers (70% alcohol).
Solvent
Draw the required volume of bacteriostatic water.
Introduction
Add gently against the vial wall (avoid a direct jet on the powder).
Solubilization
Roll the vial gently. Do not shake vigorously (degradation risk).
Solution storage Once reconstituted: 2-8°C (refrigerator).
Warning Theoretical tool for chemical handling. Does not constitute medical advice.
I open the dilution calculator- The vial carries no individual label. That is our standard packaging, not a downgraded vial.
- The parcel is plain. Nothing on the outside indicates the contents or the brand name.
What is not normal: a cracked vial, an uncrimped cap or a stopper that moves, powder that has liquefied or changed colour. In those specific cases, write to us with a photo and we take the vial back.
Technical data
- Reconstitution
- Comprimés pré-dosés, aucune reconstitution.
- Peptide sequence
- Lys-Pro-Val
- Molecular formula
- C16H30N4O4
- Molecular weight
- 342.43 g/mol
- CAS number
- 67727-97-3
- Physical form
- Comprimés oraux
- Recommended solubility
- Formulation orale pré-dosée — pas de reconstitution nécessaire
- Storage conditions
- Température ambiante, à l'abri de la lumière et de l'humidité
- Use
- Research reagent, in vitro only (RUO)
Frequently asked questions
What is the purity of KPV Oral?
How should KPV Oral be stored?
How do I reconstitute KPV Oral 100 × 500mcg?
Is a certificate of analysis (COA) available?
Is KPV Oral intended for human consumption?
What are the research applications of KPV Oral?
The complete guideKPV peptide: complete guide to the anti-inflammatory α-MSH tripeptideKPV (Lys-Pro-Val), the 11-13 fragment of α-MSH: NF-κB blockade, gut uptake via PepT1, colitis studies, colon-targeted nanoparticles, skin data, oral vs injectable KPV, dosage in studies, reconstitution and status. No human trial published.Read the guide Also read:Oral peptides in research: bioavailability changes the game
